Garrison Bradford & Associates Inc Buys Roper Technologies Inc, First Republic Bank, Sensus Healthcare Inc, Sells Celgene Corp, Basf SE, LKQ Corp

New York, NY, based Investment company Garrison Bradford & Associates Inc buys Roper Technologies Inc, First Republic Bank, Sensus Healthcare Inc, SPDR Series Trust S&P Biotech, Codexis Inc, Enbridge Inc, Stryker Corp, Alibaba Group Holding, The Home Depot Inc, ConocoPhillips, sells Celgene Corp, Basf SE, LKQ Corp, Bristol-Myers Squibb Company, Lazard World Trust Fund, Qualcomm Inc, WisdomTree Europe SmallCap Dividend Fund, General Electric Co, Alerian MLP, Nuveen AMT-Free Municipal Income Fund, MFA Financial Inc, Utilico Emerging Markets Trust PLC, Ohr Pharmaceutical Inc during the 3-months ended 2019Q1, according to the most recent filings of the investment company, Garrison Bradford & Associates Inc. As of 2019Q1, Garrison Bradford & Associates Inc owns 77 stocks with a total value of $115 million. These are the details of the buys and sells.

For the details of GARRISON BRADFORD & ASSOCIATES INC's stock buys and sells, go to https://www.gurufocus.com/guru/garrison+bradford+%26+associates+inc/current-portfolio/portfolio

These are the top 5 holdings of GARRISON BRADFORD & ASSOCIATES INC
  1. UnitedHealth Group Inc (UNH) - 93,653 shares, 20.16% of the total portfolio. Shares reduced by 4.47%
  2. Blackstone Mortgage Trust Inc (BXMT) - 348,037 shares, 10.47% of the total portfolio. Shares reduced by 5.58%
  3. Costco Wholesale Corp (COST) - 31,115 shares, 6.56% of the total portfolio. Shares reduced by 11.26%
  4. IPG Photonics Corp (IPGP) - 35,200 shares, 4.65% of the total portfolio. Shares reduced by 4.09%
  5. Thermo Fisher Scientific Inc (TMO) - 18,950 shares, 4.52% of the total portfolio.
New Purchase: Roper Technologies Inc (ROP)

Garrison Bradford & Associates Inc initiated holding in Roper Technologies Inc. The purchase prices were between $258.8 and $341.97, with an estimated average price of $302.79. The stock is now traded at around $357.13. The impact to a portfolio due to this purchase was 0.55%. The holding were 1,850 shares as of .

New Purchase: SPDR Series Trust S&P Biotech (XBI)

Garrison Bradford & Associates Inc initiated holding in SPDR Series Trust S&P Biotech. The purchase prices were between $71.21 and $91.92, with an estimated average price of $84.86. The stock is now traded at around $83.64. The impact to a portfolio due to this purchase was 0.31%. The holding were 3,950 shares as of .

New Purchase: Codexis Inc (CDXS)

Garrison Bradford & Associates Inc initiated holding in Codexis Inc. The purchase prices were between $15.53 and $22.15, with an estimated average price of $19.38. The stock is now traded at around $19.56. The impact to a portfolio due to this purchase was 0.24%. The holding were 13,500 shares as of .

New Purchase: Enbridge Inc (ENB)

Garrison Bradford & Associates Inc initiated holding in Enbridge Inc. The purchase prices were between $31.08 and $37.63, with an estimated average price of $35.96. The stock is now traded at around $36.82. The impact to a portfolio due to this purchase was 0.21%. The holding were 6,720 shares as of .

New Purchase: Stryker Corp (SYK)

Garrison Bradford & Associates Inc initiated holding in Stryker Corp. The purchase prices were between $152.46 and $198, with an estimated average price of $179.51. The stock is now traded at around $186.69. The impact to a portfolio due to this purchase was 0.19%. The holding were 1,100 shares as of .

New Purchase: Alibaba Group Holding Ltd (BABA)

Garrison Bradford & Associates Inc initiated holding in Alibaba Group Holding Ltd. The purchase prices were between $130.6 and $187.25, with an estimated average price of $167.49. The stock is now traded at around $189.35. The impact to a portfolio due to this purchase was 0.18%. The holding were 1,150 shares as of .

Added: First Republic Bank (FRC)

Garrison Bradford & Associates Inc added to a holding in First Republic Bank by 27.51%. The purchase prices were between $84.34 and $105.44, with an estimated average price of $98.3. The stock is now traded at around $103.16. The impact to a portfolio due to this purchase was 0.52%. The holding were 27,351 shares as of .

Added: Sensus Healthcare Inc (SRTS)

Garrison Bradford & Associates Inc added to a holding in Sensus Healthcare Inc by 275.09%. The purchase prices were between $7.02 and $9.23, with an estimated average price of $7.72. The stock is now traded at around $6.22. The impact to a portfolio due to this purchase was 0.48%. The holding were 108,400 shares as of .

Sold Out: Celgene Corp (CELG)

Garrison Bradford & Associates Inc sold out a holding in Celgene Corp. The sale prices were between $64.09 and $94.34, with an estimated average price of $87.12.

Sold Out: Bristol-Myers Squibb Company (BMY)

Garrison Bradford & Associates Inc sold out a holding in Bristol-Myers Squibb Company. The sale prices were between $45.12 and $53.8, with an estimated average price of $49.88.

Sold Out: Lazard World Trust Fund (WTR)

Garrison Bradford & Associates Inc sold out a holding in Lazard World Trust Fund. The sale prices were between $3.03 and $3.44, with an estimated average price of $3.32.

Sold Out: Alerian MLP (AMLP)

Garrison Bradford & Associates Inc sold out a holding in Alerian MLP. The sale prices were between $8.73 and $10.2, with an estimated average price of $9.79.

Sold Out: General Electric Co (GE)

Garrison Bradford & Associates Inc sold out a holding in General Electric Co. The sale prices were between $7.28 and $10.88, with an estimated average price of $9.4.

Sold Out: Ohr Pharmaceutical Inc (OHRP)

Garrison Bradford & Associates Inc sold out a holding in Ohr Pharmaceutical Inc. The sale prices were between $1.72 and $3.55, with an estimated average price of $2.38.



Here is the complete portfolio of GARRISON BRADFORD & ASSOCIATES INC. Also check out:

1. GARRISON BRADFORD & ASSOCIATES INC's Undervalued Stocks
2. GARRISON BRADFORD & ASSOCIATES INC's Top Growth Companies, and
3. GARRISON BRADFORD & ASSOCIATES INC's High Yield stocks
4. Stocks that GARRISON BRADFORD & ASSOCIATES INC keeps buying